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Objective To determine the prevalence of termination of
pregnancy for fetal anomaly (TOPFA) after 23 weeks of gestation
in European countries, and describe the spectrum of anomalies
for which late TOPFA is recorded.
Design Population-based study.
Setting Twelve European countries.
Population Nineteen registries of congenital anomaly in 12
European countries between 2000 and 2005. The number of total
births covered was 2 695 832.
Methods TOPFAs in singleton pregnancies from the European
Surveillance of Congenital Anomalies and Twins (EUROCAT)
database.
Main outcome measures The prevalence of TOPFA and type of
anomaly.
Results There were 10 233 TOPFAs, 678 (6.6%) of which were
performed at 24 weeks or more. The rate of TOPFA before
24 weeks was 3.4 per 1000 births, at 24–25 weeks 0.14 per 1000
births and at 26 weeks or more 0.11 per 1000 births. There was
significant variation in the prevalence of TOPFA at ‡24 weeks
between countries (P < 0.001), with all countries in the range
0–0.55 per 1000 births, except France (Paris) at 2.65 per 1000
births. The large majority of late TOPFAs had a gestational age of
24–27 weeks (516/678, 76%). The proportion of TOPFAs from
24 weeks or more varied by type of anomaly, with 4% of all
TOPFAs for chromosomal anomalies and 9% of all TOPFAs for
nonchromosomal anomalies resulting in late TOPFA (P < 0.001).
For transposition of the great arteries, single ventricle, hypoplastic
left heart and hydrocephaly, the percentage of late TOPFA was
12–23%. The median time interval between diagnosis and late
TOPFA was 2 weeks for most anomalies, but longer (‡5 weeks)
for diaphragmatic hernia, omphalocoele, arthrogryposis multiplex
and Turner’s syndrome.
Conclusion Late TOPFA is rare in Europe, and varies in
prevalence between countries. Compared with earlier TOPFA, late
TOPFA is more often performed for a nonchromosomal isolated
major structural anomaly and less often for a fetus with a
chromosomal syndrome or multiple anomalies.
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Introduction
Most terminations of pregnancy for fetal anomaly (TOP-
FAs) occur during the second trimester of pregnancy,
before fetal viability. In rare circumstances, TOPFA is
performed late in pregnancy. The laws on performing
TOPFA vary between countries within Europe,1 and may
specify no upper gestational age (GA) limit for any TOP-
FA, no upper GA limit for lethal anomalies, a GA limit for
any TOPFA or no TOPFA at any GA.
*Austria (Martin Haeusler, Graz), Belgium (Yves Gillerot, Hainault; Vera Nelen, Antwerp), Denmark (Ester Garne, Odense), France (Babak Khoshnood,
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Epidemiology
There are few published data on the prevalence of
TOPFA at a GA of 24 weeks or more, beyond the viability
limit and the type of anomalies diagnosed in these preg-
nancies. A French study2 described the termination of
pregnancy after 12 weeks of gestation from 1989 to 2000
for all fetal and maternal indications. In 74% of all termi-
nations, the indication was fetal anomaly (39% with struc-
tural malformations and 35% with chromosomal
anomalies). Although the percentage of TOPFA after
24 weeks was stable over time, an increasing prevalence of
late TOPFA reflected an increase in the prevalence of all
TOPFA. A British study from 1995 to 20043 found that
8.4% of TOPFAs were performed with a GA of 24 weeks
or more.
In this article, we determine the prevalence of TOPFA
from a GA of 24 weeks in 19 regions in 12 European coun-
tries in which TOPFA is legal, and describe the spectrum
of congenital anomalies for TOPFA.
Materials and methods
The study was based on routinely collected data from 19
European Surveillance of Congenital Anomalies and Twins
(EUROCAT) registries in 12 European countries in which
TOPFA is legal:1 Austria (Styria), Belgium (Hainault and
Antwerp), Denmark (Odense), France (Paris), Germany
(Saxony-Anhalt), Italy (Tuscany, Emilia-Romagna, Campa-
nia), the Netherlands (Groningen), Norway, Portugal
(South Portugal), Switzerland (Vaud), Ukraine, and Eng-
land and Wales (East Midlands & South Yorkshire,
Northern England, Thames Valley, Wales and Wessex).
The study years were 2000–05, except for France and
Ukraine where only 2005 data were available. The total
number of registered births (live and stillbirths) covered in
the study period for the 19 regions was 2 695 832.
The EUROCAT registries are all population based,
recording all live births, stillbirths and TOPFA with con-
genital anomaly in their populations. A description of the
geographically defined populations and the methods of case
ascertainment for EUROCAT is given at www.eurocat-
network.eu.
The registries are based on multiple sources of informa-
tion, including hospital records, birth and death certificates,
and postmortem examinations, and include information
about live births, fetal deaths at GA ‡ 20 weeks and termi-
nations of pregnancy after prenatal diagnosis of fetal anom-
aly at any GA (TOPFA). All structural malformations,
syndromes and chromosomal anomalies are included in the
database, except for minor anomalies specified on a list for
exclusion. Case information includes type of birth (live
birth, fetal death or termination of pregnancy), GA at pre-
natal diagnosis (at first suspicion or positive test) and GA
at delivery (birth or termination). Up to eight anomalies
per case and syndrome, if present, are coded according to
the International Classification of Diseases v9 (ICD9)/Brit-
ish Paediatric Association (BPA) or ICD10/BPA, and the
cases are allocated to subgroups of anomalies based on the
ICD codes. All cases not diagnosed with a chromosomal
anomaly are classified as nonchromosomal, and this
includes cases that have not been karyotyped. All TOPFA
cases with GA ‡ 24 weeks with multiple anomalies (more
than one organ system, excluding associations, chromo-
somal anomalies and monogenic syndromes) were identi-
fied using the EUROCAT multiple anomaly computer
algorithm, followed by manual review by a panel of medi-
cal geneticists.
All terminations of pregnancy in singletons only were
included in the study. Data were extracted from the central
database, and local registries then confirmed GA at termi-
nation for all TOPFA with a GA of 24 weeks or more.
We defined late TOPFA to be GA ‡ 24 weeks of gesta-
tion, because of general agreement on a viability limit at
24 weeks.
We calculated the prevalence of TOPFA at <24 and
‡24 weeks of gestation for each country (based on the
corresponding registry data) with 95% Poisson exact con-
fidence intervals (CIs); the denominators were the total
number of births in the population base for the EURO-
CAT areas within each country. The proportion of termi-
nations at <24 and ‡24 weeks of gestation were
estimated with 95% binomial exact CIs for each country,
as well as for the overall study population. For the latter,
clustering by country was taken into account in the cal-
culation of binomial Wald CIs. The median GAs at diag-
nosis and at termination, as well as the median
difference between GAs at diagnosis and termination,
were calculated with 95% linear interpolation binomial-
based CIs.
Results
During the study period, there were 10 233 TOPFAs
reported in singleton pregnancies. GA was unknown for
451 of these cases (4.4%). Among the 9782 TOPFAs with
known GAs, 5396 (55%) were diagnosed with nonchromo-
somal anomalies and 4386 (45%) were diagnosed with a
chromosomal anomaly.
TOPFA with GA of less than 24 weeks accounted for
93% of all TOPFAs, a rate of 3.4 per 1000 births (range,
1.4–7.1 per 1000 births) (Table 1). TOPFA with
GA ‡ 24 weeks accounted for 7% (678 cases).
Eleven countries performed TOPFAs at 24–25 weeks of
gestation [prevalence, 0.14 per 1000 births (range, 0.03–
0.97 per 1000 births)]. Ten countries reported TOPFA at
26 weeks of gestation or more [prevalence, 0.11 per 1000
births (range, 0.03–1.68 per 1000 births)]. The total rate of
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TOPFA at 24 weeks or more varied from 0 to 2.65 per
1000 births in the 12 countries: the variation between
countries was highly statistically significant (P < 0.001)
(Figure 1).
The large majority of late TOPFAs had a GA at 24–
27 weeks (516/678, 76%) and 162 TOPFAs had a GA of
28 weeks or more (Figure 2).
For structural anomalies, 498/5396 (9%) of TOPFAs had
a GA of 24 weeks or more, whereas, for cases with chro-
mosomal anomalies, 180/4386 (4%) had a GA of 24 weeks
or more (P < 0.001).
The proportion of late TOPFA varied by type of anom-
aly (Table 2). Those that were difficult to diagnose by
ultrasound (hydrocephalus, severe cardiac malformations)
Table 1. Number of terminations of pregnancy for fetal anomaly (TOPFAs) by country, and prevalence of TOPFA before and after 24 weeks of
gestation, 2000–05 (for regions covered within the countries, see Materials and methods)
Country* GA
< 24
weeks
GA =
24–25
weeks
GA = 26
+ weeks
GA
NK
Total
TOPFA
cases
Total
births
Prevalence of
TOPFA < 24
weeks per
1000 births
(95% CI)
Prevalence of
TOPFA at 24–25
weeks per 1000
births (95% CI)
Prevalence of
TOPFA from
26 weeks per
1000 births
(95% CI)
Total
TOPFA
prevalence
per 1000
births
Austria 176 10 10 0 196 62 667 2.8 (2.4–3.3) 0.16 (0.08–0.29) 0.16 (0.08–0.29) 3.1 (2.7–3.6)
Belgium 422 49 48 42 561 182 467 2.3 (2.1–2.5) 0.27 (0.20–0.36) 0.26 (0.19–0.35) 3.1 (2.8–3.3)
Denmark 109 2 0 0 111 32 003 3.4 (2.8–4.1) 0.06 (0.00–0.23) 0.0 3.5 (2.9–4.2)
England &
Wales
4075 119 143 241 4578 951 001 4.3 (4.2–4.4) 0.13 (0.10–0.15) 0.15 (0.13–0.18) 4.8 (4.7–5.0)
France** 182 26 45 0 253 26 715 6.8 (5.9–7.9) 0.97 (0.64–1.42) 1.68 (1.23–2.26) 9.5 (8.4–10.7)
Germany 359 17 6 3 385 106 257 3.4 (3.0–3.7) 0.16 (0.09–0.26) 0.06 (0.02–0.12) 3.6 (3.3–4.0)
Italy 2115 116 0 151 2382 686 894 3.1 (2.9–3.2) 0.17 (0.14–0.20) 0.0 3.5 (3.3–3.6)
Netherlands 161 0 6 3 170 118 971 1.4 (1.2–1.6) 0.0 0.05 (0.02–0.11) 1.4 (1.2–1.7)
Norway 958 11 12 4 985 346 838 2.8 (2.6–2.9) 0.03 (0.02–0.06) 0.03 (0.02–0.06) 2.8 (2.7–3.0)
Portugal 175 17 15 3 210 113 310 1.5 (1.3–1.8) 0.15 (0.09–0.24) 0.13 (0.07–0.22) 1.9 (1.6–2.1)
Switzerland 303 7 5 4 319 42 874 7.1 (6.3–7.9) 0.16 (0.07–0.34) 0.12 (0.04–0.27) 7.4 (6.7–8.3)
Ukraine** 69 3 11 0 83 25 835 2.7 (2.1–3.4) 0.12 (0.02–0.34) 0.43 (0.21–0.76) 3.2 (2.6–4.0)
Total 9104 377 301 451 10 233 2 695 832 3.4 (3.3–3.4) 0.14 (0.13–0.15) 0.11 (0.10–0.13) 3.8 (3.7–3.9)
CI, confidence interval; GA, gestational age; NK, not known.
*Legal situation regarding late TOPFA: no GA limit for severe anomalies (Austria, Belgium, England and Wales, France, Germany); no GA limit
if lethal (Netherlands, Norway, Portugal, Switzerland, Denmark); upper GA limit [Italy (24 weeks/fetal viability), Ukraine (28 weeks)].
**For France and Ukraine, only 2005.
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Figure 1. Prevalence of terminations of pregnancy for fetal anomaly (TOPFAs) in 12 European countries, 2000–5.
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had a higher proportion of late TOPFAs than those that
were more easily seen on ultrasound, such as anencephalus
and abdominal wall defects.
For chromosomal anomalies, the highest proportion of
late TOPFAs was for trisomy 13, with 6.4% of all TOPFAs
with a GA of 24 weeks or more (Table 3).
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Figure 2. Distribution of gestational age (GA) for termination of pregnancy for fetal anomaly (TOPFA) with GA from 24 weeks.
Table 2. Number of terminations of pregnancy for fetal anomaly (TOPFAs) by selected types of nonchromosomal anomaly, proportion of TOPFAs
with gestational age (GA) of 24 weeks or more, median GA at diagnosis and median GA at TOPFA
Congenital anomaly type* Total
TOPFA
cases (n)
Percentage of
anomalies with
TOPFA ‡ 24 weeks
(95% CI)
Median GA at
diagnosis in
weeks,
TOPFA ‡ 24
weeks** (95% CI)
Median GA
in weeks at
TOPFA ‡ 24
weeks (95% CI)
All anomalies excluding diagnosed
chromosomal anomalies
5396 9.2 (8.5–10.0) 23 (23–23) 25 (25–25)
Anencephalus and similar 864 2.5 (1.6–3.8) 23 (22–24) 25 (24–28)
Encephalocoele 180 2.2 (0.6–5.6) 24.5 (22–29) 26.5 (24–30)
Spina bifida*** 754 7.3 (5.5–9.4) 23 (23–24) 25 (24–26)
Hydrocephaly*** 560 14.3 (11.5–17.5) 23 (23–24) 26 (25–27)
Arhinencephaly/holoprosencephaly 138 12.3 (7.3–19.0) 24.5 (23–28) 26 (25–32)
Congenital heart disease 976 12.2 (10.2–14.4) 23 (22–24) 25 (24–25)
Transposition of great vessels 51 15.7 (7.0–28.6) 22.5 (22–29) 24 (24–30)
Single ventricle 43 23.3 (11.8–38.6) 23.5 (22–29) 25 (24–28)
Atrioventricular septal defect 88 13.6 (7.2–22.6) 22 (20–23) 24.5 (24–26)
Hypoplastic left heart 282 12.1 (8.5–16.4) 23 (22–24) 24 (24–25)
Oesophageal atresia 38 10.5 (2.9–24.8) 23.5 (19–28) 26 (24–29)
Diaphragmatic hernia 95 9.5 (4.4–17.2) 21 (17–29) 26 (24–29)
Gastroschisis 72 2.8 (0.3–9.7) 23.5 (23–24) 25 (24–26)
Omphalocoele 234 3.4 (1.5–6.6) 18 (13–33) 24.5 (24–34)
Bilateral renal agenesis 216 8.8 (5.4–13.4) 23 (22–25) 25 (24–26)
Arthrogryposis multiplex congenita 64 14.1 (6.6–25.0) 20.5 (18–25) 26 (25–26)
Thanatophoric skeletal dysplasia 74 1.4 (0.03–7.3) 24 (24–24) 24 (24–24)
Monogenic syndromes + microdeletions 250 9.2 (5.9–13.5) 24 (21–26) 26 (25–28)
CI, confidence interval.
*Cases with more than one major anomally may be presented in more than one group.
**GA at diagnosis not available for 17% at late TOPFAs.
***Cases with spina + hydrocephalus counted in the spina bifida subgroup only.
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The types of anomaly diagnosed for all 678 TOPFAs with
a GA of 24 weeks or more are presented in Table 4.
Twenty-seven percent of all late TOPFAs were caused by
chromosomal anomalies and 73% were caused by major
structural anomalies. Ten percent of late TOPFAs were for
multiple anomalies, 6% for monogenic syndromes and the
remaining 57% for isolated major structural anomalies.
For all 678 TOPFAs with a GA of 24 weeks or more, the
median GA at diagnosis was 23 weeks and the median GA
at TOPFA was 25 weeks. For four anomalies, the median
time interval between diagnosis and late TOPFA was more
than 5 weeks: diaphragmatic hernia, omphalocoele, arthro-
gryposis multiplex and Turner’s syndrome.
Discussion
In our study population of 12 European countries in which
TOPFA is legal, we found, on average, approximately one
late TOPFA per 4000 births (0.25 per 1000 births) for the
period 2000–05. More than one-half of these terminations
of pregnancy were performed following the diagnosis of a
major anomaly of a single organ system. We do not know
from our registry data whether the anomaly diagnosed was
the sole reason for the termination. There may also have
been other conditions contributing to a poor prognosis,
such as severe fetal growth restriction, severe hydrops,
severe oligohydramnios or additional maternal factors.
The rate of TOPFA with a GA of 24 weeks or more var-
ied considerably between countries, from less than 0.1 per
1000 births in the Netherlands (Groningen), Denmark
(Odense) and Norway, to 2.65 per 1000 in France (Paris),
with all countries other than France having rates under 0.6
per 1000. There was a poor relationship between the preva-
lence of early terminations and the prevalence of late ter-
minations—a point illustrated by the fact that both France
(Paris) and Switzerland (Vaud) showed high rates of termi-
nation before 24 weeks (6.8 and 7.1 per 1000, respectively),
whereas Paris had a much higher rate of termination after
24 weeks than Vaud. Several other studies have reported
previously a high prevalence of late TOPFA in France.2,4,5
The variations in TOPFA rates in Europe have been
reported previously.1,5,6
In Paris, the second trimester anomaly scan tends to be
performed later than in other European countries. An ear-
lier analysis of EUROCAT registry data showed the median
GA at diagnosis for structural anomalies was 22 weeks in
Table 3. Diagnosed chromosomal anomalies: number of terminations of pregnancy for fetal anomaly (TOPFAs), proportion of TOPFAs with
gestational age (GA) of 24 weeks or more, median GA at diagnosis and median GA at TOPFA
Total TOPFA
chromosomal
cases with
known GA
Percentage of
chromosomal
anomalies with
TOPFA ‡ 24
weeks (95% CI)
Median GA
in weeks at
diagnosis,
TOPFA ‡ 24
weeks* (95% CI)
Median GA
in weeks at
TOPFA
(95% CI)
All chromosomal cases 4386 4.1 (3.5–4.7) 23 (22–23) 25 (25–26)
Down’s syndrome 2285 2.3 (1.7–3.0) 23 (22–23) 24 (24–25)
Patau syndrome/trisomy 13 298 6.4 (3.9–9.8) 24 (22–27) 26 24–27)
Edward syndrome/trisomy 18 749 6.0 (4.4–8.0) 23 (23–24) 25 (24–26)
Turner’s syndrome 344 2.3 (1.0–4.5) 18 (12–26) 25 (24–26)
CI, confidence interval.
*GA at diagnosis not known for 17% of all late TOPFA cases.
Table 4. Distribution by organ system for terminations of
pregnancy for fetal anomaly (TOPFAs) with a gestational age (GA)
of 24 weeks or more (n = 678). All cases only counted once in the
table
Type of anomaly Number
of cases
Percentage
of total
Neural tube defects* 76 11
Hydrocephalus* 59 9
Other cerebral anomalies* 44 6
Cardiac defects* 73 11
Respiratory* 10 <1
Gastrointestinal anomalies* 11 <1
Abdominal wall defects* 8 <1
Renal anomalies* 49 7
Other isolated anomalies 52 8
Multiple anomalies 67 10
Monogenic syndrome
or microdeletion
43 6
Down’s syndrome 53 8
Trisomy 13 19 3
Trisomy 18 42 6
Other chromosomal 72 11
Total 678 100
*As isolated anomaly.
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Paris, compared with 19–20 weeks in registries in Belgium,
Italy and the UK.6 As our data suggest that the median
time from prenatal diagnosis to termination is 2 weeks,
having a relatively late GA for the anomaly scan would
result in more TOPFA after 24 weeks. Nevertheless, Paris
also had a higher TOPFA rate from 26 weeks of gestation,
suggesting a higher acceptability of late termination in this
population. Paris, like some but not all European countries,
also has a recommended third trimester scan.1
There are some limitations to our data. The areas covered
by EUROCAT are not necessarily representative of the entire
country. Furthermore, it is possible that some late TOPFAs
were recorded in the EUROCAT registers as stillbirths or live
births (i.e. early birth inductions) rather than TOPFA,
depending on local medical practice. In some areas, TOPFA
performed outside the registry area may not be known to the
registry, as in Saxony-Anhalt, Germany. This may also be the
case in countries with an upper GA limit for TOPFA. In the
Ukraine, the legal limit for TOPFA was 28 weeks during the
study period (2005), but was reduced to 22 weeks in 2006.
Terminations after 24 weeks, although a small proportion
of all TOPFAs, nevertheless constitute a potentially large pro-
portion of perinatal deaths or stillbirths. Countries vary in
terms of the legal requirement to register late TOPFA as a
live or stillbirth, and in terms of whether perinatal mortality
associated with TOPFA can be distinguished from other
perinatal mortality.5 The Models of Organising Access to
Intensive Care for very preterm babies (MOSAIC) study5
published termination of pregnancy rates for European
regions for a GA of 22–31 weeks for 2003 for any indication
(fetal and maternal). The data sets are not completely com-
parable but, given the high rates of termination of pregnancy
after 22 weeks in the MOSAIC study, it may be that there is
some under-reporting of TOPFA as stillbirths in the current
study. Until there is harmonisation of recording practices,
late TOPFA creates difficulties in the interpretation of the
variation between countries in stillbirth and perinatal
mortality rates. On the one hand, late TOPFA may decrease
perinatal mortality rates when it is not civilly registered, but
may also increase perinatal mortality rates when it is per-
formed for nonlethal anomalies and is civilly registered.5,7
The spectrum of anomalies in late TOPFA differs from
that of early TOPFA, with a higher proportion of structural
anomalies and a lower proportion of chromosomal anoma-
lies. We also found that 57% of TOPFAs with a GA of
24 weeks or more are performed after prenatal diagnosis of
an isolated major structural anomaly, and the proportion of
multiple anomalies was only 10% (Table 4). The proportion
of multiple malformed cases is lower than that found in two
other studies from single centres.4,8 Single-centre studies
may be biased towards tertiary referral centres.
Certain anomalies were particularly likely to be associ-
ated with late termination, including single ventricle,
transposition of the great vessels, arthrogryposis multiplex
and hydrocephaly, for which more than 14% of all
terminations were at 24 weeks or later. The distribution
of the isolated major anomalies in late TOPFA, with a
high proportion of cerebral anomalies in our European
multicentre study, is comparable with that of other
regional studies published in France (Isere, Paris), UK
(Northern Region) and Israel.2,4,8,9 Two of these studies
presented data on third trimester terminations
(GA ‡ 28 weeks).4,8
The median time interval from diagnosis to termination
was 2 weeks. A reasonable time interval is needed between
diagnosis and termination of pregnancy to allow referral
to specialists and prenatal counsellors, to wait for karyo-
type results, to allow parents to reach an informed deci-
sion, and to obtain permission for termination from a
committee or more than one doctor. In four anomalies,
we found a median time interval of more than 1 month
from prenatal diagnosis to termination: diaphragmatic
hernia, omphalocoele, arthrogryposis multiplex and
Turner’s syndrome. Turner’s syndrome is an example in
which termination is most frequently performed when
severe fetal hydrops is diagnosed late in gestation. In the
case of diaphragmatic hernia, liver herniation suggests a
poor prognosis and may influence the decision to termi-
nate. Other indications, such as lung hypoplasia in dia-
phragmatic hernia and fetal akinesia in arthrogryposis late
in pregnancy, may also influence the prognosis and the
decision to terminate.
It was not our purpose in this article to discuss the ethi-
cal or psychological aspects of late termination. We note,
however, that the general consensus is that ethical and psy-
chological acceptability of TOPFA is greater the earlier in
pregnancy in which it is performed.10
There is a balance to be reached, which takes into
account cultural and ethical considerations, between having
an earlier anomaly scan policy which allows earlier TOPFA
or a later scan policy with a higher and sometimes more
accurate prenatal detection rate, but resulting in later
TOPFA. There may be situations in which it is necessary to
follow the development of an anomaly to see if the fetus
deteriorates in the weeks following a diagnosis, for example
after a prenatal diagnosis of less severe hydrocephalus. The
availability of late TOPFA may allow parents to make a
decision on the basis of more accurate information from a
later investigation.
Addendum
TOPFA rates and rates before and after 20 weeks of
gestation, for the most recent 5 years, can be found at the
EUROCAT website: www.eurocat-network.eu. These data
are updated annually.
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